January 5, 2024 - Page 3 of 12

NYSE Companies - January 5, 2024

Grupo Aeroportuario del Pacifico Reports in December 2023 a Passenger Traffic Increase of 2.2% Compared to 2022

GUADALAJARA, Mexico, Jan. 05, 2024 (GLOBE NEWSWIRE) — Grupo Aeroportuario del Pacífico, S.A.B. de C.V., (NYSE: PAC; BMV: GAP) (“the […]

NASDAQ Companies - January 5, 2024

Semantix Provides Update Regarding Nasdaq Minimum Bid Price Compliance

SÃO PAULO, Brazil, Jan. 05, 2024 (GLOBE NEWSWIRE) — Semantix, Inc. (NASDAQ: STIX), a leading Latin American enterprise AI platform […]

NASDAQ Companies - January 5, 2024

Triumph Financial Announces Schedule for Fourth Quarter 2023 Earnings Release and Conference Call

DALLAS, Jan. 05, 2024 (GLOBE NEWSWIRE) — Triumph Financial, Inc. (Nasdaq: TFIN) today announced that it expects to release its […]

NASDAQ Companies - January 5, 2024

Societal CDMO Reports Inducement Grants for New Staff

SAN DIEGO and GAINESVILLE, Ga., Jan. 05, 2024 (GLOBE NEWSWIRE) — Societal CDMO, Inc. (“Societal CDMO”; NASDAQ: SCTL), a contract […]

NASDAQ Companies - January 5, 2024

Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BOSTON, Mass., Jan. 05, 2024 (GLOBE NEWSWIRE) — Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering […]

NASDAQ Companies - January 5, 2024

Senti Bio Announces Strategic Steps to Prioritize Investment in Lead Clinical Program

– Strategic resource allocation to focus investment on clinical development of SENTI-202 and SENTI-301A partnership in China; interim data from […]

NASDAQ Companies - January 5, 2024

Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

BRISBANE, Calif., Jan. 05, 2024 (GLOBE NEWSWIRE) — Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage oncology company developing first-in-class1 therapeutics […]